How effective is dog culling in controlling zoonotic visceral leishmaniasis? A critical evaluation of the science, politics and ethics behind this public health policy;Quanto é efetivo o abate de cães para o controle do calazar zoonótico? Uma avaliação crítica da ciência, política e ética por trás desta política de saúde pública

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 44, Issue 2, 2011, Pages 232-242

  Costa, Carlos Henrique Nery ^a,b  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b Instituto de Doencas Tropicais Natan Portella   (Brazil)

Author keywords

Brazil; China; Control; Dogs; Kala azar; Visceral leishmaniasis

Indexed keywords

ARTICLE; BRAZIL; CHINESE; DOG; DOG CULLING; ETHICS; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; NONHUMAN; POLITICS; PUBLIC HEALTH; RISK FACTOR; STRATEGIC PLANNING; USSR; VISCERAL LEISHMANIASIS; ZOONOSIS;

ANIMALS; BRAZIL; DISEASE RESERVOIRS; DOG DISEASES; DOGS; EUTHANASIA, ANIMAL; HUMANS; LEISHMANIASIS, VISCERAL; PUBLIC POLICY; RISK FACTORS; ZOONOSES;

ANIMALIA; CANIS FAMILIARIS; NASO HEXACANTHUS; PROTOZOA;

EID: 79957839913     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822011005000014     Document Type: Article

References (101)

1. Joshi A, Narain JP, Prasittisuk C, Bhatia R, Hashim G, Jorge A, et al. Can visceral leishmaniasis be eliminated from Asia? J Vector Borne Dis 2008; 45:105-111.
2. Zhi-Biao X. Present situation of visceral leishmaniasis in China. Parasitol Today 1989; 5:224-228.
3. Committee of experts on leishmaniasis. Control of the leishmaniases. Geneva: World Health Organization. Technical Report Series; 1993.
4. Lukes J, Mauricio IL, Schonian G, Dujardin JC, Soteriadou K, Dedet JP, et al. Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci U S A 2007; 104:9375-9380.
5. Mauricio IL, Gaunt MW, Stothard JR, Miles MA. Glycoprotein 63 (gp63) genes show gene conversion and reveal the evolution of Old World Leishmania. Int J Parasitol 2007; 37:565-576.
6. Mauricio IL, Stothard JR, Miles MA. The strange case of Leishmania chagasi. Parasitol Today 2000; 16:188-189.
7. Herwaldt BL. Leishmaniasis. Lancet 1999; 354:1191-1199.
8. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27:305-318.
9. Romero GA, Boelaert M. Control of visceral leishmaniasis in Latin America: a systematic review. PLoS Negl Trop Dis 2010; 4:e584.
10. Adler S, Tchernomoretz I. Failure to cure natural canine visceral leishmaniasis. Ann Trop Med Parasitol 1946; 40:320-325.
11. Hoare A. Reservoir hosts and natural foci of human protozoal infections. Acta Tropica 1962; 19:281-317.
12. Leng YJ. A review of kala-azar in China from 1949 to 1959. Trans R Soc Trop Med Hyg 1982; 76:531-537.
13. Zhong HL, Zhang NZ. Studies on leishmaniasis in China. Historical background, epidemiology, clinical aspects, legislature and control program. Chin Med J (Engl) 1986; 99:281-300.
14. Lu C, Chung H, Ling C, Wu C, Wang C, Chiang Y. New China's achievements in the treatment and prevention of kala-azar. Chin Med J (Engl) 1955; 78:91-99.
15. Wang CT, Wu CC. Studies on kala-azar in new China. Chin Med J 1959; 78:55-71.
16. Guan LR, Shen WX. Recent advances in visceral leishmaniasis in China. Southeast Asian J Trop Med Public Health 1991; 22:291-298.
17. Zhang LM, Leng YJ. Eighty-year research of phlebotomine sandflies (Diptera: Psychodidae) in China (1915-1995). II. Phlebotomine vectors of leishmaniasis in China. Parasite 1997; 4:299-306.
18. Chung H-L. A résumé of kala-azar work in China. Chin Med J (Engl) 1953; 71:421-464.
19. Wu C. Some achievements on the study of kala-azar in New China. Chin Med J (Engl) 1958; 77:307-309.
20. Lu HG, Zhong L, Guan LR, Qu JQ, Hu XS, Chai JJ, et al. Separation of Chinese Leishmania isolates into five genotypes by kinetoplast and chromosomal DNA heterogeneity. Am J Trop Med Hyg 1994; 50:763-770.
21. Lysenko A, Lubova V. Epidemiology and geography of visceral leishmanisis in the URSS. Colloque Internationaux du CNRS no 239; 1977; Paris: Écologie de leishmanioses; 1977. p. 253-256.
22. Kellina OI. Problem and current lines in investigations on the epidemiology of leishmaniasis and its control in the U.S.S.R. Bull Soc Pathol Exot Filiales. 1981; 74:306-318.
23. Guan LR. Current status of kala-azar and vector control in China. Bull World Health Organ 1991; 69:595-601.
24. Mao SB. Control of parasitic diseases in China: achievements and prospects. Chin Med J (Engl) 1987; 100:445-453.
25. Yu S. Control of parasitic diseases in China. Current status and prospects. Chin Med J (Engl) 1996; 109:259-265.
26. Bao Y, Wang ST, Shao QF. A further study of LDT and IFAT tests in evaluating the control of kala-azar in China. J Trop Med Hyg 1994; 97:357-361.
27. Alam MZ, Haralambous C, Kuhls K, Gouzelou E, Sgouras D, Soteriadou K, et al. The paraphyletic composition of Leishmania donovani zymodeme MON-37 revealed by multilocus microsatellite typing. Microbes Infect 2009; 11:707-715.
28. Lysenko AJ. Distribution of leishmaniasis in the Old World. Bull World Health Organ 1971; 44:515-520.
29. Turusov V, Rakitsky V, Tomatis L. Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks. Environ Health Perspect 2002; 110:125-128.
30. Sen Gupta P. Return of kala-azar. J Indian Med Assoc 1975; 65:89-90.
31. Thakur CP, Kumar M, Pathak PK. Kala-azar hits again. J Trop Med Hyg 1981; 84:271-276.
32. Kumar V, Kesari S, Kumar AJ, Dinesh DS, Ranjan A, Prasad M, et al. Vector density and the control of kala-azar in Bihar, India. Mem Inst Oswaldo Cruz 2009; 104:1019-1022.
33. Dhillon GP, Sharma SN, Nair B. Kala-azar elimination programme in India. J Indian Med Assoc 2008; 106:664,666-668.
34. Joshi AB, Das ML, Akhter S, Chowdhury R, Mondal D, Kumar V, et al. Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal. BMC Med 2009; 7:54.
35. Bern C, Courtenay O, Alvar J. Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination. PLoS Negl Trop Dis 2010; 4:e599.
36. Costa CH. Characterization and speculations on the urbanization of visceral leishmaniasis in Brazil. Cad Saude Publica 2008; 24:2959-2963.
37. Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2008; 2:e313.
38. Ministério da Saúde. Série histórica de óbitos e casos de doenças de notificação compulsória no Brasil (1980-2005). Brasília: Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Coordenação Geral de Vigilância Epidemiológica; 2006.
39. Committee of experts on primary healthcare (Brasil). Manual de Vigilância e Controle da Leishmaniose Visceral: Ministério da Saúde. Brasília: Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica; 2004.
40. Salomon O, Sinagra A, Nevot M, Barberian G, Paulin P, Estevez J, et al. First visceral leishmaniasis focus in Argentina. Mem Inst Oswaldo Cruz 2008; 103:109-111.
41. Lacerda MM. The Brazilian leishmaniasis control program. Mem Inst Oswaldo Cruz 1994; 89:489-495.
42. Alencar J. Profilaxia do calazar no Ceará, Brasil. Rev Inst Med Trop Sao Paulo 1961; 3:175-180.
43. Magalhaes PA, Mayrink W, Costa CA, Melo MN, Dias M, Batista SM, et al. Calazar na zona do Rio Doce-Minas Gerais. Resultados de medidas profiláticas. Rev Inst Med Trop Sao Paulo 1980; 22:197-202.
44. Malaquias LCC, Romualdo RC, do Anjos Jr JB, Giunchetti RC, Correa-Oliveira R, Reis AB. Serological screening confirms the re-emergence of canine leishmaniosis in urban and rural areas in Governador Valadares, Vale do Rio Doce, Minas Gerais, Brazil. Parasitol Res 2007; 100:233-239.
45. Marzochi MC, Fagundes A, Andrade MV, Souza MB, Madeira MF, Mouta-Confort E, et al. Visceral leishmaniasis in Rio de Janeiro, Brazil: eco-epidemiological aspects and control. Rev Soc Bras Med Trop 2009; 42:570-580.
46. Costa CHN, Pereira HF, Araujo MV. Epidemia de leishmaniose visceral no Estado do Piauí, Brasil (1980-1986). Rev Saude Publica 1990; 24:361-372.
47. Deane LM, Deane MP. Visceral leishmaniasis in Brazil: geographical distribution and transmission. Rev Inst Med Trop Sao Paulo 1962; 4:198-212.
48. Costa CH, Vieira JB. Changes in the control program of visceral leishmaniasis in Brazil. Rev Soc Bras Med Trop 2001; 34:223-228.
49. Schantz PM, Steurer FJ, Duprey ZH, Kurpel KP, Barr SC, Jackson JE, et al. Autochthonous visceral leishmaniasis in dogs in North America. J Am Vet Med Assoc 2005; 226:1316-1322.
50. Margonari C, Freitas CR, Ribeiro RC, Moura AC, Timbo M, Gripp AH, et al. Epidemiology of visceral leishmaniasis through spatial analysis, in Belo Horizonte municipality, state of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2006; 101:31-38.
51. Costa C, Moura M, Pereira F. Fatores de risco urbanos para a ocorrência de leishmaniose visceral. Rev Soc Bras Med Trop 1995; 28(supl I):7
52. Gavgani AS, Hodjati MH, Mohite H, Davies CR. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002; 360:374-379.
53. Oliveira CD, Assuncao RM, Reis IA, Proietti FA. Spatial distribution of human and canine visceral leishmaniasis in Belo Horizonte, Minas Gerais State, Brasil, 1994-1997. Cad Saude Publica 2001; 17:1231-1239.
54. Werneck GL, Costa CH, Walker AM, David JR, Wand M, Maguire JH. Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol Infect 2007; 135:195-201.
55. Werneck GL, Costa CH, Walker AM, David JR, Wand M, Maguire JH. The urban spread of visceral leishmaniasis: clues from spatial analysis. Epidemiology 2002; 13:364-367.
56. Kotkat A, el-Daly S, el-Daaw A, Barakat R. Immunological investigation of visceral leishmaniasis among school children in Alexandria. J Egypt Soc Parasitol 1986; 16:449-456.
57. Moreno EC, Melo MN, Genaro O, Lambertucci JR, Serufo JC, Andrade AS, et al. Risk factors for Leishmania chagasi infection in an urban area of Minas Gerais State. Rev Soc Bras Med Trop 2005; 38:456-463.
58. Gouvea MV, Werneck GL, Costa CH, Amorim Carvalho FA. Factors associated to Montenegro skin test positivity in Teresina, Brazil. Acta Trop 2007; 104:99-107.
59. nd Epidemiologic study of visceral leishmaniasis in Honduras, 1975-1983. Am J Trop Med Hyg 1985; 34:1069-1075.
60. Costa CH, Pereira HF, Pereira FC, Tavares JP, Araujo MV, Goncalves MJ. Is the household dog a risk factor for American visceral leishmaniasis in Brazil? Trans R Soc Trop Med Hyg 1999; 93:464.
61. Caldas AJ, Costa JM, Silva AA, Vinhas V, Barral A. Risk factors associated with asymptomatic infection by Leishmania chagasi in north-east Brazil. Trans R Soc Trop Med Hyg 2002; 96:21-28.
62. Nascimento MDSB. Epidemiologia da leishmaniose visceral na Ilha de São Luis, Maranhão, Brasil: análise da dinâmica de transmissão e dos fatores de risco relacionados ao desenvolvimento da doença. [Doctor in Medicine]. [São Paulo]: Universidade Federal de São Paulo; 1996.
63. Quinnell RJ, Courtenay O. Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 2009; 136:1915-1934.
64. Adler S, Theodor O. Transmission of disease agents by phlebotomine sand flies. Annual Rev Ent. 1957; 2:203.
65. Sherlock IA, Sherlock V. Sôbre a infecção experimental de Phlebotomus longipalpis pela Leishmania donovani. Rev Bras Biol 1961; 21:409-418.
66. Molina R, Amela C, Nieto J, San-Andres M, Gonzalez F, Castillo JA, et al. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans R Soc Trop Med Hyg 1994; 88:491-493.
67. Michalsky EM, Rocha MF, Rocha Lima AC, Franca-Silva JC, Pires MQ, Oliveira FS, et al. Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies. Vet Parasitol 2007; 147:67-76.
68. Costa CH, Gomes RB, Silva MR, Garcez LM, Ramos PK, Santos RS, et al. Competence of the human host as a reservoir for Leishmania chagasi. J Infect Dis 2000; 182:997-1000.
69. Rogers DJ. The dynamics of vector-transmitted diseases in human communities. Philos Trans R Soc Lond B Biol Sci 1988; 321:513-539.
70. Mather T, Wilson M, Moore S, Ribeiro J, Spielman A. Comparing the relative potential of rodents as reservoirs of the Lyme disease spirochete (Borrelia burgdorferi). Am J Epidemiol 1989; 130:143-150.
71. Dye C. The logic of visceral leishmaniasis control. Am J Trop Med Hyg 1996; 55:125-130.
72. Burattini M, Coutinho F, Lopez L, Massad E. Modelling the dynamics of leishmaniasis considering human, animal host and vector populations. J Biological Systems 1998; 4:337-356.
73. Dietze R, Barros GB, Teixeira L, Harris J, Michelson K, Falqueto A, et al. Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil. Clin Infect Dis. 1997; 25:1240-1242.
74. Ashford DA, David JR, Freire M, David R, Sherlock I, Eulalio MC, et al. Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg 1998; 59:53-57.
75. Costa CH, Tapety CM, Werneck GL. Controle da leishmaniose visceral em meio urbano: estudo de intervenção randomizado fatorial. Rev Soc Bras Med Trop 2007; 40:415-419.
76. Souza V, Bisinoto T, Julião F, Lima A, Neves R. Communitary assay for assessment of effectiveness of strategies for prevention and control of human visceral leishmaniasis in the municipality of Feira de Santana, State of Bahia, Brazil. Epidemiol Serv Saude 2008; 17:97-106.
77. McGarity TO, Wagner WE. Bending Science: how special interests corrupt public health research. 1st ed. Cambridge: Harvard University Press; 2008.
78. Organización Panamericana de la Salud. Organización Mundial de la Salud. Encuentro sobre vigilancia, prevención y control de leishmaniasis visceral (LV) en el Cono Sur de Sudamérica. Foz do Iguazú, Brasil. 2009 - [cited 2010 Nov 21] Available from: http://new.paho.org/panaftosa/index.php?option=com_docman&task=doc_download&gid=79/.
79. Committee of experts on leishmaniasis. II Forum de discussão sobre o tratamento da leishmaniose visceral canina. Brasilia: Ministério da Saúde. Secretaria de Vigilância em Saúde; 2009.
80. Manchikanti L. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations. Pain Physician 2008; 11:161-186.
81. Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 1. Guidelines for guidelines. Health Res Policy Syst 2006; 4:13.
82. Fretheim A, Schunemann HJ, Oxman AD. Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst 2006; 4:15.
83. Diamond GA, Denton TA. Alternative perspectives on the biased foundations of medical technology assessment. Ann Intern Med 1993; 118:455-464.
84. Committee of experts on dengue. Dengue: diagnóstico e manejo clínico - adulto e criança. 3a ed. Brasília: Diretoria Técnica de Gestão. Secretaria de Vigilância em Saúde. Ministério da Saúde; 2007.
85. Committee of experts on leishmaniasis, Committee of experts on HIV infection and Aids. Recomendações para diagnóstico, tratamento e acompanhamento da co-infecção Leishmania-HIV. Brasília: Programa Nacional de DST e Aids. Secretaria de Vigilância em Saúde. Ministério da Saúde; 2004.
86. Committee of experts on primary health care. Vigilância em saúde: dengue, esquistossomose, hanseníase, malária, tracoma e tuberculose. 2a ed. Brasília: Secretaria de Atenção a Saúde. Departamento de Atenção Básica. Ministério da Saúde; 2008.
87. Committee of experts on tegumentar leishmaniasis. Leishmaniose Visceral Grave: Normas e Condutas. 1st ed. Brasília: Coordenação Geral de Vigilância Epidemiológica. Departamento de Vigilância Epidemiológica. Secretaria de Vigilância em Saúde. Ministério da Saúde; 2006. p.51.
88. Committee of experts on tegumentar leishmaniasis. Manual de vigilância da leishmaniose tegumentar americana. 2a ed. Brasília: Editora do Ministério da Saúde; 2010.
89. Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet 2000; 356:1565-1569.
90. Picado A, Das ML, Kumar V, Kesari S, Dinesh DS, Roy L, et al. Effect of villagewide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis 2010; 4:e587.
91. Alexander B, Maroli M. Control of phlebotomine sandflies. Med Vet Entomol 2003; 17:1-18.
92. Palatnik-de-Sousa C. Vaccines for leishmaniasis in the fore coming 25 years. Vaccine 2008; 26:1709-1724.
93. Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F. Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res 2006; 123:423-438.
94. Kedzierski L, Zhu Y, Handman E. Leishmania vaccines: progress and problems. Parasitology. 2006; 133(suppl):S87-112.
95. Rogan WJ, Chen A. Health risks and benefits of bis(4-chlorophenyl)-1,1,1- trichloroethane (DDT). Lancet 2005; 366:763-773.
96. Guimaraes RM, Asmus CI, Meyer A. DDT reintroduction for malaria control: the cost-benefit debate for public health. Cad Saude Publica 2007; 23:2835-2844.
97. Data WLC-i-P. International Health Regulation. 2005 - [cited April 3 2010]. Available from: http://whqlibdoc.who.int/HQ/2003/EIP_GPE_EQC_2003_1.pdf/.
98. World Health Organization. Global Programme on Evidence for Health Policy. Guidelines for WHO guidelines. Geneva: World Health Organization; 2003.
99. Committee on Assessing Integrity in Research Environments. Integrity in scientific research: creating an environment that promotes responsible conduct. Washington (DC): The National Academies Press; 2002.
100. The moral status of animals. Stanford Encyclopedia of Philosophy 2003 - [cited Feb 21th 2010]. Available from: http://plato.stanford.edu/entries/moralanimal/.
101. Emery NJ, Clayton NS. Comparative social cognition. Annu Rev Psychol 2009; 60:87-113.